AzTrials
AzTrials

DysphoniaNCT06124053

Investigation of the Effectiveness of Group Voice Therapy in Children

A study testing Group Voice Therapy, Individual Voice Therapy and Vocal Hygiene Education in people with Dysphonia, run by Hacettepe University at 1 site in Turkey (Türkiye).

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to investigate whether there is a difference between groups receiving "group voice therapy" and "individual voice therapy" in pediatric populations diagnosed with dysphonia. Read more about this study

Who is it for?
Ages 7 to 11 years
Conditions the study is for
Dysphonia
What is being tested?
Group Voice Therapy, Individual Voice Therapy and Vocal Hygiene Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Nov 2023to 30 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 11 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Having been diagnosed with vocal fold lesions.
  • Being referred to Hacettepe University Speech and Language Therapy Department for a diagnosis of voice disorder by Hacettepe University Ear, Nose, and Throat Department.
  • Being in the age range of 7-11.
  • Having Turkish as the native language.

Who cannot join

  • Having a history of any upper respiratory tract infection up to two weeks before the date of data collection (it is requested to consider the last two weeks as a reference in one of the questionnaires to be filled out).
  • Having any known neurological, systemic, or endocrinological disease that affects one's voice.
  • Having undergone any surgical intervention related to the voice or received voice therapy before the research process.
  • Having a diagnosis of current hearing loss.
  • Having a neurological or psychiatric diagnosis.
  • The family or child not wanting to participate in the study.
  • Not having acquired reading and writing skills yet

Trial locations and contacts

1 site in 1 country.

Özlem BEŞİK TOPÇU, SLP contact

(+90)5385032233

ozlembesik@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Hacettepe University, Speech and Language Therapy

    Ankara

    Özlem Beşik Topçu, SLP, (+90)5385032233, ozlembesik@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Comparing Outcomes of Group Voice Therapy and Individual Voice Therapy in Children With Dysphonia Between the Ages of 7-11

This study aims to investigate whether there is a difference between groups receiving "group voice therapy" and "individual voice therapy" in pediatric populations diagnosed with dysphonia. In this context, the goal is to comprehensively examine the effectiveness of "group voice therapy" in pediatric populations compared to similar studies in the literature. In line with this objective, it is aimed to comprehensively test its effectiveness by including perceptual and acoustic evaluation findings, objective and subjective assessments, and incorporating comparison and control groups into the study, as compared to similar studies in the literature.

Read the detailed description

There are three groups in total in the study: two research groups and one control group. The first research group will receive "group voice therapy". Group voice therapy sessions are arranged in groups of three. A total of eight sessions will be given, one session per week. The second research group will receive "individual voice therapy". In this context, participants will be given individual voice therapy for a total of eight sessions, one session per week. The voice therapy approach to be applied to participants receiving individual voice therapy and group voice therapy includes direct and indirect voice therapy methods.Control group participants will receive a one-session "vocal hygiene training".

Control group participants will be evaluated before and after vocal hygiene training. The first and second research groups will be evaluated four times in total: before therapy, after therapy, third month follow-up and sixth month follow-up. It is aimed to examine the effectiveness of "group voice therapy" by comparing the findings obtained from the approaches. Objective and subjective evaluation tools will be used in the evaluations. It is expected that Research Group 1, receiving "group voice therapy," and Research Group 2, receiving "individual voice therapy," will demonstrate a significant decrease in the primary outcome measure, the GRBAS score, and secondary outcome measures, including the Pediatric Voice Handicap Index score, the Teacher's Perception-Based Voice Handicap Index score, and a significant increase in the Pediatric Voice-Related Quality of Life Scale score when comparing pre-therapy and post-therapy assessments. It is anticipated that these significant changes will be sustained in the follow-up evaluations.

Conditions
Dysphonia
Being tested
Group Voice Therapy, Individual Voice Therapy, Vocal Hygiene Education
Keywords
voice therapy, group voice therapy, pediatric voice disorders, pediatric voice therapy
Medical subject headings
Dysphonia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group Voice TherapyBehavioural

    The "group voice therapy" intervention consists of a total of eight sessions. The session contents include both direct and indirect voice therapy approaches. Each group is composed of three participants. The session durations are planned to be 45-60 minutes each.

  • Individual Voice TherapyBehavioural

    The "individual voice therapy" intervention consists of a total of eight sessions. The session contents include both direct and indirect voice therapy approaches. The session durations are planned to be 45-60 minutes each.

  • Vocal Hygiene EducationBehavioural

    Regarding vocal hygiene training, information related to voice production and respiratory characteristics will be provided, and guidance on correct and incorrect voice use will be given.

Study groups in NCT06124053
Study groupRoleWhat they receive
Group Voice TherapyExperimentalIn this research, a total of eight sessions of "group voice therapy" will be applied as the intervention approach. It is planned that each group will consist of three participants. Participants will be evaluated before the intervention, after the intervention, at the third-month follow-up assessment, and at the sixth-month follow-up assessment. Both formal and informal assessment tools have been preferred for the evaluation. Researchers will collect case histories and demographic information. For the acoustic assessment of the participants, voice recordings will be obtained through the ComputerizedSpeech Lab (CLS) program. GRBAS scores will be conducted by the researchers, while Pediatric Voice Handicap Index (pVHI) and Pediatric Voice Related Quality of Life (pVRQOL) scales will be filled out by parents.
Receives: Behavioral: Group Voice Therapy
Individual Voice TherapyActive comparatorIn this research, a total of eight sessions of "individual voice therapy" will be implemented as the intervention approach. Participants will be evaluated before the intervention, after the intervention, at the third-month follow-up assessment, and at the sixth-month follow-up assessment. Both formal and informal assessment tools have been chosen for the evaluation. Researchers will collect case histories and demographic information. For the acoustic assessment of the participants, voice recordings will be obtained through the CLS program. GRBAS scores will be conducted by the researchers, while pVHI and pVRQOL scales will be filled out by parents or guardians.
Receives: Behavioral: Individual Voice Therapy
Vocal Hygiene EducationActive comparatorParticipants will receive a one-session "vocal hygiene training." Participants will be evaluated twice: once before the vocal hygiene training and again 8 weeks after the vocal hygiene training. Both formal and informal assessment tools have been preferred for the evaluation. Researchers will collect case histories and demographic information. For the acoustic assessment of the participants, voice recordings will be obtained through the CLS program. GRBAS scores will be conducted by the researchers, while pVHI and pVRQOL scales will be filled out by parents.
Receives: Behavioral: Vocal Hygiene Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes observed in the GRBAS score

    The changes observed in the GRBAS parameters between pre-intervention and post-intervention evaluations.

    Measured: Change from the baseline to tenth week

  2. Changes observed in the GRBAS score

    The changes observed in the GRBAS parameters between pre-intervention and post-intervention evaluations.

    Measured: Change from the baseline to third month follow-up evaluation

  3. Changes observed in the GRBAS score

    The changes observed in the GRBAS parameters between pre-intervention and post-intervention evaluations.

    Measured: Change from the baseline to sixth month follow-up evaluation

Secondary outcomes (9)
  1. The change observed in the Pediatric Voice Handicap Index score

    The changes observed in the Pediatric Voice Handicap Index total score and subscale scores between pre-intervention and post-intervention evaluations.

    Measured: Change from the baseline to tenth week

  2. The change observed in the Pediatric Voice Related Quality of Life score

    The changes observed in the Pediatric Voice Quality of Life score and scores between pre-intervention and post-intervention evaluations.

    Measured: Change from the baseline to tenth week

  3. Change in Acoustic Voice Characteristics

    The changes observed in the F0, Jitter, Shimmer, and Noise to Harmonic Ratio values for the sustain /a/ phonation recording obtained through the Multi-Dimensional Voice Program (MDVP) by Kaypentax Computerized Speech Lab between pre-therapy and post-therapy evaluations.

    Measured: Change from the baseline to tenth week

  4. The change observed in the Pediatric Voice Handicap Index score

    The changes observed in the Pediatric Voice Handicap Index total score and subscale scores between pre-intervention and post-intervention evaluations.

    Measured: Change from the baseline to third month follow-up evaluation

  5. The change observed in the Pediatric Voice Related Quality of Life score

    The changes observed in the Pediatric Voice Quality of Life score and scores between pre-intervention and post-intervention evaluations.

    Measured: Change from the baseline to third month follow-up evaluation

  6. Change in Acoustic Voice Characteristics

    The changes observed in the F0, Jitter, Shimmer, and Noise to Harmonic Ratio values for the sustain /a/ phonation recording obtained through the Multi-Dimensional Voice Program (MDVP) by Kaypentax Computerized Speech Lab between pre-therapy and post-therapy evaluations.

    Measured: Change from the baseline to third month follow-up evaluation

  7. The change observed in the Pediatric Voice Handicap Index score

    The changes observed in the Pediatric Voice Handicap Index total score and subscale scores between pre-intervention and post-intervention evaluations.

    Measured: Change from the baseline to sixth month follow-up evaluation

  8. The change observed in the Pediatric Voice Related Quality of Life score

    The changes observed in the Pediatric Voice Quality of Life score and scores between pre-intervention and post-intervention evaluations.

    Measured: Change from the baseline to sixth month follow-up evaluation

  9. Change in Acoustic Voice Characteristics

    The changes observed in the F0, Jitter, Shimmer, and Noise to Harmonic Ratio values for the sustain /a/ phonation recording obtained through the Multi-Dimensional Voice Program (MDVP) by Kaypentax Computerized Speech Lab between pre-therapy and post-therapy evaluations.

    Measured: Change from the baseline to sixth month follow-up evaluation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Nov 2023
  2. Study start15 Nov 2023
  3. Primary completion30 Nov 2024 (estimated)
  4. Study completion30 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Participants will be grouped based on the Grade scores on the GRBAS scale using a stratified sampling method.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
18 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06124053
Sponsor's protocol ID
HUSLP_GROUPVOICETHERAPY
Status last verified
Nov 2023
First submitted
16 Oct 2023
Last updated
21 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Group Voice Therapy, Individual Voice Therapy and Vocal Hygiene Education in people with Dysphonia, run by Hacettepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Özlem BEŞİK TOPÇU, SLP ((+90)5385032233, ozlembesik@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes observed in the GRBAS score (time frame: Change from the baseline to tenth week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in